Stražar, Martin
Temba, Godfrey S.
Vlamakis, Hera http://orcid.org/0000-0003-1086-9191
Kullaya, Vesla I.
Lyamuya, Furaha http://orcid.org/0000-0002-2319-8246
Mmbaga, Blandina T. http://orcid.org/0000-0002-5550-1916
Joosten, Leo A. B. http://orcid.org/0000-0001-6166-9830
van der Ven, Andre J. A. M.
Netea, Mihai G. http://orcid.org/0000-0003-2421-6052
de Mast, Quirijn http://orcid.org/0000-0001-6056-157X
Xavier, Ramnik J. http://orcid.org/0000-0002-5630-5167
Funding for this research was provided by:
U.S. Department of Health & Human Services | National Institutes of Health (P30DK043351)
Article History
Received: 15 December 2020
Accepted: 30 June 2021
First Online: 11 August 2021
Change Date: 24 August 2021
Change Type: Correction
Change Details: A Correction to this paper has been published:
Change Details: https://doi.org/10.1038/s41467-021-25472-z
Change Date: 29 September 2021
Change Type: Correction
Change Details: A Correction to this paper has been published:
Change Details: https://doi.org/10.1038/s41467-021-26145-7
Competing interests
: R.J.X. is a consultant to Novartis and co-founder of Celsius Therapeutics and Jnana Therapeutics. Other authors declare no competing interests.